Structure Therapeutics Inc.

US$20.35As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GPCRHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (5.99%)
Div yield —
ROE (20.21%)
Biotechnology
Beta (5Y) (1.20)
PE TTM —
TSR TTM (38.93%)
Mkt cap US$1.451B
ROIC (15.65%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$24
20.21%
302.80%
Hold 9|6|11|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.36
0.39
0.39
0.42
15.94%
12.41%
11.88%
12.14%
Revenue$M
100.5
97.67
96.24
93.38
5.29%
(2.54%)
(1.69%)
(5.17%)
Peers (US$1.451B)
Cap (US$)
PE
1.451B
—
Capital
TTM
5Y
10Y
Leveragex
4.685
0.016
0.016
EBIT/Intx
3.238
0.202
0.186
Own earn%
466.13
(16.84)
(19.29)
Sh yield%
20.74
19.11
19.43
Owners
Insiders/Inst%
8.72
26.92
Short interest%
0.84
SBC / revenue%
0.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
3–7
$1 testx
1.0
Incr. ROIC%
26